Tadalafil

Trade Name: 
Adcirca
Manufacturer/Distributor: 
Eli Lilly Canada
www.lilly.ca; 1-888-545-5972
Classification: 
cGMP-specific phosphodiesterase type 5 inhibitor
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2009/11/25
Date Marketed in Canada (yyyy/mm/dd): 
2009/11/25
Presentation: 
tablet: 20 mg, DIN: 02338327
Comments: 
Indicated for the treatment of idiopathic (primary) pulmonary arterial hypertension (PAH) or PAH associated with connective tissue disease, congential heart disease or anorexigen use in patients with WHO functional class II or III who have not responded to conventional therapy.